I hear you don't worry. Several of my posts have been on the valuation models too of the product. The best I can deduce is that there should be 600 E profit for each product sold. Still a healthy margin in any language. For me the real kicker is going to be the FDA approval mid next year. USA is a HUGE market as we know. And as someone has alluded to - the more we make the less per unit cost. All bodes well.
- Forums
- ASX - By Stock
- NTI
- Neurotech Investor Roadshow 2016
Neurotech Investor Roadshow 2016, page-22
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
-0.005(6.58%) |
Mkt cap ! $72.23M |
Open | High | Low | Value | Volume |
7.6¢ | 7.8¢ | 6.9¢ | $135.0K | 1.833M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27000 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 33439 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27000 | 0.070 |
2 | 46286 | 0.069 |
2 | 41617 | 0.068 |
1 | 25000 | 0.067 |
4 | 258292 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 33439 | 1 |
0.073 | 172720 | 1 |
0.075 | 37501 | 3 |
0.076 | 66000 | 1 |
0.077 | 42000 | 1 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online